Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial

Ta Chung Chao, Zyting Chu, Ling Ming Tseng, Tzeon Jye Chiou, Ruey Kuen Hsieh, Wei Shu Wang, Chueh Chuan Yen, Muh Hwa Yang, Liang Tsai Hsiao, Jin Hwang Liu, Po Min Chen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences